Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Biological Psychiatry|October 20, 1998
Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free periodR P Sharma, J I Javaid, J M Davis, et al.
Psychiatry Research|April 1, 1989
Increased 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disordersG N Pandey, P G Janicak, J I Javaid, et al.
Schizophrenia Research|July 5, 1996
Age of illness onset and schizophrenic symptomatology during an inpatient washout periodR P Sharma, S M Dowd, J M Davis, et al.
The American Journal of Psychiatry|December 1, 1995
Elevation of CSF somatostatin concentrations in maniaR P Sharma, G Bissette, P G Janicak, et al.
Psychiatry Research|January 1, 1994
CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatmentsR P Sharma, J I Javaid, K Faull, et al.
Biological Psychiatry|August 1, 1993
Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatmentR P Sharma, J I Javaid, P G Janicak, et al.
Schizophrenia Research|September 10, 1999
The prolactin response to fenfluramine in schizophrenia is associated with negative symptomsR P Sharma, V Singh, P G Janicak, et al.
Psychopharmacology Bulletin|January 1, 1992
The efficacy of psychotropic drugs: implications for power analysisJ M Davis, P G Janicak, Z Wang, et al.
Psychopharmacology Bulletin|January 1, 1991
Steady-state plasma level prediction for haloperidol from a single test doseJ I Javaid, P G Janicak, D Hedeker, et al.
Psychiatry Research|December 13, 2001
Hyperactive phosphoinositide signaling pathway in platelets of depressed patients: effect of desipramine treatmentG N Pandey, X Ren, S C Pandey, et al.
Pageof 7